Merck (MRK) Price to Earnings (2009 - 2026)

Merck (MRK) has reported Price to Earnings for 18 consecutive years, with 237.12 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Earnings fell 631.03% year-over-year to 237.12 in Q2 2026; TTM through Jun 2026 was 100.04, a 730.69% increase from a year earlier, with the FY2025 full-year figure at 14.25, down 2.84% from the prior year.
• Price to Earnings was 237.12 for Q2 2026 at Merck, down from 70.02 in the prior quarter.
• Over five years, Price to Earnings peaked at 95.56 in Q1 2023 and troughed at 237.12 in Q2 2026.
• A 5-year average of 18.59 and a median of 56.19 in 2023 frame the typical range for Price to Earnings.
• Across the five-year window, Price to Earnings surged 217.2% in 2024 and tumbled 631.03% in 2026, its largest moves.
• Over 5 years, Price to Earnings stood at 93.33 in 2022, then plunged by 341.32% to 225.21 in 2023, then surged by 129.8% to 67.12 in 2024, then soared by 30.9% to 87.86 in 2025, then sank by 369.88% to 237.12 in 2026.
• The last three Price to Earnings figures came in at 237.12 (Q2 2026), 70.02 (Q1 2026), and 87.86 (Q4 2025), per Business Quant data.